Sharon Shacham
@sharonshacham4413
Director
Building Acrivon Therapeutics, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Acrivon Therapeutics, Inc. was founded in 2018 and has no closure on record.
Named alongside
- Derek DiRoccoDirector
- Eric DevroeExecutive Officer
- Erick GamelinExecutive Officer
- Kristina MassonExecutive Officer, Director
- Marcin CzernikDirector
- Peter Blume-JensenExecutive Officer, Director
- Dalia MegiddoChief Development Officer and Chief Medical Officer
- Dan TelemanChief Executive Officer
- David SilbermanDirector
- Eyal RubinChief Financial Officer and Executive Vice President
- Isaac IsraelDirector
- Ronnie HershmanDirector
- Udi GilboaDirector
- Lynda ChinDirector
- Raju KucherlapatiDirector
Contribution
Sharon's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Acrivon Therapeutics, Inc.Pharmaceutical Preparations; listed on Nasdaq as ACRV; filing with the SEC since 2021Director · Biotechnology · Cambridge, United States · Founded 2018
- Regenimo Biosciences, Inc.Executive Officer, Director · Biotechnology · HOUSTON, United States · Founded 2025
- Nasus Pharma LtdPharmaceutical Preparations; listed on NYSE as NSRX; filing with the SEC since 2024Director · Biotechnology · TEL AVIV